PMC Stock Overview
Engages in the production and distribution of pharmaceutical products for the Vietnamese community. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Pharmedic Pharmaceutical Medicinal Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫122,300.00 |
| 52 Week High | ₫135,800.00 |
| 52 Week Low | ₫73,600.00 |
| Beta | 0.34 |
| 1 Month Change | 11.28% |
| 3 Month Change | 36.34% |
| 1 Year Change | 56.59% |
| 3 Year Change | 82.54% |
| 5 Year Change | 129.46% |
| Change since IPO | 107.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 0.3% | 2.1% | -0.4% |
| 1Y | 56.6% | 35.7% | 11.9% |
Return vs Industry: PMC exceeded the VN Pharmaceuticals industry which returned 35.7% over the past year.
Return vs Market: PMC exceeded the VN Market which returned 11.9% over the past year.
Price Volatility
| PMC volatility | |
|---|---|
| PMC Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in VN Market | 6.8% |
| 10% least volatile stocks in VN Market | 2.0% |
Stable Share Price: PMC's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: PMC's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 534 | Tran Trung | www.pharmedic.com.vn |
Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the production and distribution of pharmaceutical products for the Vietnamese community. The company offers over-the-counter medicinal products, hepatobiliary systems, cardiovascular systems, respiratory systems, central nervous systems, Musculo-skeletal systems, hormones, anti-infectives, Genito-urinary systems, endocrine and metabolic systems, and vitamins and minerals, as well as eyes, ears, nose and throat, and cough treatment products. It also provides dermatological products, allergy and immune system products, functional foods, medicines from medicinal herbs, antiseptic products, anti-allergy drugs, gastrointestinal drugs, analgesic and antipyretic products, anti-inflammatory and gout treatment products, cardiovascular and diabetes products, and neuropathy products.
Pharmedic Pharmaceutical Medicinal Joint Stock Company Fundamentals Summary
| PMC fundamental statistics | |
|---|---|
| Market cap | ₫1.14t |
| Earnings (TTM) | ₫62.51b |
| Revenue (TTM) | ₫493.37b |
18.3x
P/E Ratio2.3x
P/S RatioIs PMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMC income statement (TTM) | |
|---|---|
| Revenue | ₫493.37b |
| Cost of Revenue | ₫311.61b |
| Gross Profit | ₫181.75b |
| Other Expenses | ₫119.25b |
| Earnings | ₫62.51b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.70k |
| Gross Margin | 36.84% |
| Net Profit Margin | 12.67% |
| Debt/Equity Ratio | 0% |
How did PMC perform over the long term?
See historical performance and comparisonDividends
15.6%
Current Dividend Yield82%
Payout RatioDoes PMC pay a reliable dividends?
See PMC dividend history and benchmarks| Pharmedic Pharmaceutical Medicinal dividend dates | |
|---|---|
| Ex Dividend Date | Dec 12 2024 |
| Dividend Pay Date | Dec 25 2024 |
| Days until Ex dividend | 10 days |
| Days until Dividend pay date | 3 days |
Does PMC pay a reliable dividends?
See PMC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 04:48 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pharmedic Pharmaceutical Medicinal Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|